Delivery Order SPE2DR25D6044-SPE2DR26FYA4J
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Misoprostol 100 microgram tablets in unit dose packaging of 100 units. This competitively awarded, firm fixed-price contract carries a ceiling value of $1,319.56 and is scheduled for completion by September 17, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX),...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Misoprostol 200 microgram tablets in unit dose packaging (100 count) under a firm fixed price contract valued at $2,683.99, with a completion date of December 2, 2025. This non-competitive delivery order was issued under AmerisourceBergen's existing Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.9 billion prime vendor agreement that runs through December 2026 and...
- This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,316.70 firm fixed-price delivery order is for the supply of 100 units of Misoprostol 200 mcg tablets. The contract, which has an ultimate completion date of June 28, 2022, is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Mifepristone 300 mg tablets in a 28-day supply quantity, with a ceiling value of $84,653.44. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of September 4, 2025, and performance will occur at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child contract under the company's broader pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $80,243.07 to AmerisourceBergen Drug Corp for the supply of Mifepristone 300 mg tablets (quantity 28) on October 21, 2025, with an ultimate completion date of October 22, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $102,535.75 to AmerisourceBergen Drug Corp for the supply of Mifepristone 300 mg tablets (28-count units) with a completion date of July 30, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC)...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Methylergonovine 0.2 mg tablets in quantities of 12 units, with a contract ceiling value of $1,470.46. This firm fixed-price delivery order, which is scheduled for completion by November 5, 2025, will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a non-competitive delivery order issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Methylergonovine 0.2 mg tablets (28-count) with a ceiling value of $6,856.84. This is a firm fixed-price delivery order with an ultimate completion date of December 8, 2025, and represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- This is a delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of mifepristone 300 mg tablets, a medication used for certain medical purposes. The contract has a ceiling value of $81,104.15 and is a firm-fixed-price contract. The contract is not set-aside and is therefore open to full and open competition. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Methylergonovine 0.2 mg tablets in quantities of 12 units, with a ceiling value of $1,209.92. This is a firm fixed price delivery order with an ultimate completion date of July 30, 2025, and represents a non-set-aside competitive award. The contract will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DR25D6044Indefinite Delivery Contract
- SPE2DR25D6044-SPE2DR26FYA4JDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Misoprostol 100 MCG tablets in unit dose packaging of 100s, with a ceiling value of $1,583.98 and an ultimate completion date of December 12, 2025. This firm fixed-price delivery order represents a non-competitive award and is classified as a child contract under AmerisourceBergen's larger procurement vehicle. The place of performance is the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply agreement running through December 2026. As a major pharmaceutical distributor, AmerisourceBergen serves as a critical vendor for federal medical procurement, supplying a wide range of pharmaceutical products and medical supplies to support military healthcare programs, the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The delivery order for Misoprostol, a medication used for gastrointestinal and gynecological applications, reflects the company's ongoing role as a primary vendor within DLA's Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 12/10/25 |